for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Cymabay therapeutics announces results from mid-phase clinical study of MBX-8025

March 17 (Reuters) - - :

* Cymabay Therapeutics Inc announces positive results from its pilot phase 2 clinical study of MBX-8025 in patients with homozygous familial hypercholesterolemia

* Cymabay Therapeutics Inc announces plans to evaluate feasibility of conducting a pilot study of MBX-8025 in combination with a PCSK9 inhibitor Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up